

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 9.90233102 |
| 2 | B cell mediated immunity (GO:0019724) | 7.76035319 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 7.48587153 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.06832508 |
| 5 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 7.06728891 |
| 6 | regulation of antigen processing and presentation (GO:0002577) | 6.14225792 |
| 7 | positive regulation of antigen processing and presentation (GO:0002579) | 5.72465313 |
| 8 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.69992769 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.38199098 |
| 10 | positive T cell selection (GO:0043368) | 5.05156084 |
| 11 | DNA deamination (GO:0045006) | 4.90658828 |
| 12 | L-fucose catabolic process (GO:0042355) | 4.86955756 |
| 13 | fucose catabolic process (GO:0019317) | 4.86955756 |
| 14 | L-fucose metabolic process (GO:0042354) | 4.86955756 |
| 15 | T-helper 1 type immune response (GO:0042088) | 4.63008438 |
| 16 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.47202262 |
| 17 | production of molecular mediator of immune response (GO:0002440) | 4.40817662 |
| 18 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.36437803 |
| 19 | regulation of B cell apoptotic process (GO:0002902) | 4.29589052 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.25764628 |
| 21 | T cell costimulation (GO:0031295) | 4.25270405 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.23969566 |
| 23 | cellular response to interferon-gamma (GO:0071346) | 4.21123605 |
| 24 | lymphocyte costimulation (GO:0031294) | 4.19504497 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.19256619 |
| 26 | negative regulation of B cell apoptotic process (GO:0002903) | 4.15541157 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 3.96873453 |
| 28 | positive regulation of macrophage cytokine production (GO:0060907) | 3.91587229 |
| 29 | negative regulation of mast cell activation (GO:0033004) | 3.85197293 |
| 30 | response to interferon-gamma (GO:0034341) | 3.83733087 |
| 31 | detection of bacterium (GO:0016045) | 3.81233768 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66400809 |
| 33 | response to interferon-beta (GO:0035456) | 3.61302297 |
| 34 | positive regulation of interferon-beta production (GO:0032728) | 3.58935385 |
| 35 | detection of other organism (GO:0098543) | 3.46147789 |
| 36 | regulation of mast cell activation (GO:0033003) | 3.37242406 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.36715819 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.36579275 |
| 39 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.32826549 |
| 40 | mast cell degranulation (GO:0043303) | 3.31850694 |
| 41 | mast cell activation involved in immune response (GO:0002279) | 3.31850694 |
| 42 | growth hormone receptor signaling pathway (GO:0060396) | 3.29523687 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.28939989 |
| 44 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.28342635 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22139826 |
| 46 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.20538144 |
| 47 | response to host immune response (GO:0052572) | 3.19235185 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19235185 |
| 49 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 3.15270225 |
| 50 | antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 3.15270225 |
| 51 | thymic T cell selection (GO:0045061) | 3.13961333 |
| 52 | lymphocyte mediated immunity (GO:0002449) | 3.13648111 |
| 53 | mast cell activation (GO:0045576) | 3.13007960 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 3.11045422 |
| 55 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.10248240 |
| 56 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.10247338 |
| 57 | negative T cell selection (GO:0043383) | 3.03247032 |
| 58 | microglial cell activation (GO:0001774) | 3.02170123 |
| 59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01657598 |
| 60 | platelet dense granule organization (GO:0060155) | 2.96710962 |
| 61 | T cell receptor signaling pathway (GO:0050852) | 2.94768284 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94748819 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 2.94748819 |
| 64 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.94651962 |
| 65 | regulation of interferon-beta production (GO:0032648) | 2.92947232 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.92273392 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92273392 |
| 68 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92273392 |
| 69 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92273392 |
| 70 | modulation by symbiont of host immune response (GO:0052553) | 2.92273392 |
| 71 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92273392 |
| 72 | cellular response to growth hormone stimulus (GO:0071378) | 2.92232870 |
| 73 | regulation of macrophage cytokine production (GO:0010935) | 2.91338775 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91037951 |
| 75 | response to host (GO:0075136) | 2.91037951 |
| 76 | response to host defenses (GO:0052200) | 2.91037951 |
| 77 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.89417019 |
| 78 | positive regulation of prostaglandin secretion (GO:0032308) | 2.88611885 |
| 79 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.86821454 |
| 80 | tryptophan metabolic process (GO:0006568) | 2.84901793 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84886428 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.84843324 |
| 83 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.84542369 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 2.81711542 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.81497077 |
| 86 | T cell selection (GO:0045058) | 2.79298230 |
| 87 | monoamine transport (GO:0015844) | 2.78670507 |
| 88 | plasma membrane fusion (GO:0045026) | 2.78120272 |
| 89 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.76602835 |
| 90 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.76066865 |
| 91 | positive regulation of chemokine production (GO:0032722) | 2.74315213 |
| 92 | thrombin receptor signaling pathway (GO:0070493) | 2.73638105 |
| 93 | adaptive immune response (GO:0002250) | 2.71098652 |
| 94 | positive regulation of T cell activation (GO:0050870) | 2.70705544 |
| 95 | positive regulation of interferon-gamma production (GO:0032729) | 2.67863391 |
| 96 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.67462672 |
| 97 | positive regulation of neutrophil migration (GO:1902624) | 2.67462672 |
| 98 | response to peptidoglycan (GO:0032494) | 2.66182630 |
| 99 | leukocyte mediated immunity (GO:0002443) | 2.65821702 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.65344048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.90554685 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.97770230 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.79855681 |
| 4 | CIITA_25753668_ChIP-Seq_RAJI_Human | 3.66002901 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.43618384 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25641494 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.80739191 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.24566601 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22338697 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.21207686 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20053317 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07347287 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87832900 |
| 14 | GATA3_26560356_Chip-Seq_TH2_Human | 1.86212916 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.85366374 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75525483 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73846145 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.61279476 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61133447 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61000264 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57861968 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57817242 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57780511 |
| 24 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.57009467 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.56156655 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55742234 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55493694 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52845659 |
| 29 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.52204410 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51568749 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51457870 |
| 32 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50566904 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50179485 |
| 34 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.50067016 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.49319540 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48592558 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47623068 |
| 38 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.43936444 |
| 39 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.41534002 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.41377741 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40557590 |
| 42 | AR_20517297_ChIP-Seq_VCAP_Human | 1.40196026 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.39864330 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.36618474 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34844549 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32959788 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32933295 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32589971 |
| 49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.32225444 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.30287187 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27735895 |
| 52 | P300_27268052_Chip-Seq_Bcells_Human | 1.26143497 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24180033 |
| 54 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.23382849 |
| 55 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.23382849 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22360263 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19523812 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18427272 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17340224 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15185458 |
| 61 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13766379 |
| 62 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13626005 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.13254997 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12934713 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12819353 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06326838 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05834473 |
| 68 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05702507 |
| 69 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.05552711 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04549896 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04484138 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04242468 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04242468 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03192609 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02111270 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01124254 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99328684 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.97536466 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97464252 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97179270 |
| 81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96762544 |
| 82 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96755688 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96298737 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96298737 |
| 85 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95199951 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94920941 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94450695 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.94038292 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93581177 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.93077803 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93057810 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92846957 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.92834451 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92804747 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92171883 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.91094907 |
| 97 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90934001 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90323901 |
| 99 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90202816 |
| 100 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89826829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 7.36247824 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.24004858 |
| 3 | MP0003724_increased_susceptibility_to | 3.64513995 |
| 4 | MP0003303_peritoneal_inflammation | 3.44410164 |
| 5 | MP0001800_abnormal_humoral_immune | 2.90692207 |
| 6 | MP0005671_abnormal_response_to | 2.88436374 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.74210177 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.41324123 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.36587453 |
| 10 | MP0000685_abnormal_immune_system | 2.36053496 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.34793723 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.31606603 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.28570337 |
| 14 | MP0001790_abnormal_immune_system | 2.21791407 |
| 15 | MP0005387_immune_system_phenotype | 2.21791407 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.20840839 |
| 17 | MP0002723_abnormal_immune_serum | 2.18728476 |
| 18 | MP0002420_abnormal_adaptive_immunity | 1.92916430 |
| 19 | MP0001819_abnormal_immune_cell | 1.90402818 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.82443879 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.80993930 |
| 22 | MP0009785_altered_susceptibility_to | 1.76638606 |
| 23 | MP0008872_abnormal_physiological_respon | 1.73850812 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.65841000 |
| 25 | MP0002419_abnormal_innate_immunity | 1.65378129 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.48327306 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.47825760 |
| 28 | MP0005025_abnormal_response_to | 1.46715144 |
| 29 | MP0000716_abnormal_immune_system | 1.44985266 |
| 30 | MP0002398_abnormal_bone_marrow | 1.40871899 |
| 31 | MP0002006_tumorigenesis | 1.38851058 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.37930591 |
| 33 | MP0009764_decreased_sensitivity_to | 1.36555988 |
| 34 | MP0003045_fibrosis | 1.35876182 |
| 35 | MP0001663_abnormal_digestive_system | 1.34025776 |
| 36 | MP0009278_abnormal_bone_marrow | 1.30763043 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.28347916 |
| 38 | MP0003436_decreased_susceptibility_to | 1.25496663 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.23176734 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.22349132 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20315411 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.19351749 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.17933276 |
| 44 | MP0002429_abnormal_blood_cell | 1.17883250 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.15511842 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.15511842 |
| 47 | MP0003786_premature_aging | 1.15158469 |
| 48 | MP0000613_abnormal_salivary_gland | 1.15060431 |
| 49 | MP0005410_abnormal_fertilization | 1.14926608 |
| 50 | MP0003252_abnormal_bile_duct | 1.14099330 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.14050928 |
| 52 | MP0008469_abnormal_protein_level | 1.12408102 |
| 53 | MP0001873_stomach_inflammation | 1.11623875 |
| 54 | MP0003075_altered_response_to | 1.09343279 |
| 55 | MP0000230_abnormal_systemic_arterial | 1.07174256 |
| 56 | MP0008775_abnormal_heart_ventricle | 1.05221661 |
| 57 | MP0005365_abnormal_bile_salt | 1.03798646 |
| 58 | MP0005360_urolithiasis | 1.02826008 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.00054804 |
| 60 | MP0002876_abnormal_thyroid_physiology | 0.98099894 |
| 61 | MP0001968_abnormal_touch/_nociception | 0.97681909 |
| 62 | MP0005166_decreased_susceptibility_to | 0.97185761 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.93682834 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 0.92942793 |
| 65 | MP0005595_abnormal_vascular_smooth | 0.92475582 |
| 66 | MP0003866_abnormal_defecation | 0.90004772 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 0.89654999 |
| 68 | MP0002405_respiratory_system_inflammati | 0.88546548 |
| 69 | MP0001764_abnormal_homeostasis | 0.87044971 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 0.86781501 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 0.86750891 |
| 72 | MP0002928_abnormal_bile_duct | 0.85649904 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.84025258 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.83355838 |
| 75 | MP0006054_spinal_hemorrhage | 0.83343344 |
| 76 | MP0006292_abnormal_olfactory_placode | 0.82025788 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.81014848 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.79607993 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.79470892 |
| 80 | MP0003195_calcinosis | 0.79322892 |
| 81 | MP0002722_abnormal_immune_system | 0.76715191 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.74797098 |
| 83 | MP0003646_muscle_fatigue | 0.74361341 |
| 84 | MP0002102_abnormal_ear_morphology | 0.74184952 |
| 85 | MP0003763_abnormal_thymus_physiology | 0.72264788 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.71505538 |
| 87 | MP0008995_early_reproductive_senescence | 0.71431939 |
| 88 | MP0004147_increased_porphyrin_level | 0.70364069 |
| 89 | MP0005165_increased_susceptibility_to | 0.67802358 |
| 90 | MP0002282_abnormal_trachea_morphology | 0.67611420 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.66284969 |
| 92 | MP0005310_abnormal_salivary_gland | 0.65315757 |
| 93 | MP0006082_CNS_inflammation | 0.63344847 |
| 94 | MP0004084_abnormal_cardiac_muscle | 0.61303034 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.61101238 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.60810516 |
| 97 | MP0000249_abnormal_blood_vessel | 0.60184628 |
| 98 | MP0003828_pulmonary_edema | 0.60136529 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.56646271 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 0.55725043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.62992098 |
| 2 | Abnormality of the prostate (HP:0008775) | 4.64203802 |
| 3 | Meningitis (HP:0001287) | 3.95717578 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.80723175 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 3.74604376 |
| 6 | Visual hallucinations (HP:0002367) | 3.63238156 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45430191 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45430191 |
| 9 | Hypoproteinemia (HP:0003075) | 3.44167335 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.37843728 |
| 11 | Pulmonary infiltrates (HP:0002113) | 3.34352459 |
| 12 | Vasculitis (HP:0002633) | 3.31283953 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 3.26051898 |
| 14 | Hypomagnesemia (HP:0002917) | 3.15707193 |
| 15 | Pulmonary fibrosis (HP:0002206) | 3.11134445 |
| 16 | Abnormality of B cell number (HP:0010975) | 3.09606818 |
| 17 | Testicular atrophy (HP:0000029) | 3.08959356 |
| 18 | Prostate neoplasm (HP:0100787) | 2.99551256 |
| 19 | Focal motor seizures (HP:0011153) | 2.98728668 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97536200 |
| 21 | Recurrent bronchitis (HP:0002837) | 2.95520625 |
| 22 | Type II lissencephaly (HP:0007260) | 2.80090571 |
| 23 | Recurrent fungal infections (HP:0002841) | 2.79923787 |
| 24 | Stomach cancer (HP:0012126) | 2.78235458 |
| 25 | Urticaria (HP:0001025) | 2.75631016 |
| 26 | Dyschromatopsia (HP:0007641) | 2.71484909 |
| 27 | Abnormality of male internal genitalia (HP:0000022) | 2.66904473 |
| 28 | Xerostomia (HP:0000217) | 2.60465162 |
| 29 | Abnormality of the pleura (HP:0002103) | 2.58278591 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.57810876 |
| 31 | Ureteral stenosis (HP:0000071) | 2.57155488 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.53210373 |
| 33 | IgG deficiency (HP:0004315) | 2.51699052 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.50397382 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49640147 |
| 36 | Hemoptysis (HP:0002105) | 2.49392993 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48675981 |
| 38 | Obstructive lung disease (HP:0006536) | 2.48675981 |
| 39 | Abnormality of magnesium homeostasis (HP:0004921) | 2.42324540 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.41863205 |
| 41 | Ureteral obstruction (HP:0006000) | 2.41656861 |
| 42 | Colitis (HP:0002583) | 2.41166632 |
| 43 | Chest pain (HP:0100749) | 2.39121902 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.37753044 |
| 45 | Encephalitis (HP:0002383) | 2.35790577 |
| 46 | Retinal dysplasia (HP:0007973) | 2.33651346 |
| 47 | Attenuation of retinal blood vessels (HP:0007843) | 2.29803321 |
| 48 | Recurrent skin infections (HP:0001581) | 2.29163679 |
| 49 | Cellulitis (HP:0100658) | 2.26784867 |
| 50 | Restrictive lung disease (HP:0002091) | 2.22391763 |
| 51 | Chronic sinusitis (HP:0011109) | 2.22254906 |
| 52 | Congenital stationary night blindness (HP:0007642) | 2.21955692 |
| 53 | Fair hair (HP:0002286) | 2.21786924 |
| 54 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20111110 |
| 55 | Recurrent pneumonia (HP:0006532) | 2.16204338 |
| 56 | Abnormality of T cell physiology (HP:0011840) | 2.10515272 |
| 57 | Metabolic alkalosis (HP:0200114) | 2.08496451 |
| 58 | Recurrent viral infections (HP:0004429) | 2.08294665 |
| 59 | Pustule (HP:0200039) | 2.06183710 |
| 60 | Skin rash (HP:0000988) | 2.04859626 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.03724936 |
| 62 | Recurrent lower respiratory tract infections (HP:0002783) | 2.00981815 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.00038498 |
| 64 | Optic neuritis (HP:0100653) | 2.00038498 |
| 65 | Delayed CNS myelination (HP:0002188) | 1.98433481 |
| 66 | Pulmonary embolism (HP:0002204) | 1.98030826 |
| 67 | Gangrene (HP:0100758) | 1.96356338 |
| 68 | Osteomyelitis (HP:0002754) | 1.94892022 |
| 69 | Alveolar cell carcinoma (HP:0006519) | 1.93750289 |
| 70 | Amelogenesis imperfecta (HP:0000705) | 1.91868053 |
| 71 | Inflammation of the large intestine (HP:0002037) | 1.91406807 |
| 72 | Calf muscle hypertrophy (HP:0008981) | 1.90743122 |
| 73 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89898129 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89898129 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89898129 |
| 76 | Verrucae (HP:0200043) | 1.89443908 |
| 77 | Papilloma (HP:0012740) | 1.89443908 |
| 78 | Clumsiness (HP:0002312) | 1.88996723 |
| 79 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87898499 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 1.86959178 |
| 81 | Bile duct proliferation (HP:0001408) | 1.86959178 |
| 82 | B lymphocytopenia (HP:0010976) | 1.86119834 |
| 83 | Alkalosis (HP:0001948) | 1.85820926 |
| 84 | Myositis (HP:0100614) | 1.85789014 |
| 85 | Increased corneal curvature (HP:0100692) | 1.85555187 |
| 86 | Keratoconus (HP:0000563) | 1.85555187 |
| 87 | Disproportionate short-trunk short stature (HP:0003521) | 1.83772044 |
| 88 | Hematochezia (HP:0002573) | 1.83690329 |
| 89 | J-shaped sella turcica (HP:0002680) | 1.83302964 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 1.82262577 |
| 91 | Abnormality of T cells (HP:0002843) | 1.82202866 |
| 92 | Polygenic inheritance (HP:0010982) | 1.81305021 |
| 93 | Arterial thrombosis (HP:0004420) | 1.80360042 |
| 94 | Hypothermia (HP:0002045) | 1.80130218 |
| 95 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.79793584 |
| 96 | Carpal bone hypoplasia (HP:0001498) | 1.79577955 |
| 97 | Concave nail (HP:0001598) | 1.79103221 |
| 98 | Hypertensive crisis (HP:0100735) | 1.78548322 |
| 99 | Polyuria (HP:0000103) | 1.77810799 |
| 100 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.76613292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.59898015 |
| 2 | BMPR1B | 4.22872766 |
| 3 | FRK | 3.57017145 |
| 4 | KIT | 3.46858577 |
| 5 | TLK1 | 3.39836838 |
| 6 | CDK19 | 3.01666676 |
| 7 | EIF2AK3 | 2.78923946 |
| 8 | GRK1 | 2.64046702 |
| 9 | CDK8 | 2.36940523 |
| 10 | MAP4K1 | 2.32198878 |
| 11 | PINK1 | 2.22732256 |
| 12 | FES | 2.10597124 |
| 13 | TEC | 2.09793417 |
| 14 | SYK | 2.05733659 |
| 15 | SCYL2 | 2.03053632 |
| 16 | TAOK3 | 2.02040245 |
| 17 | BMPR2 | 2.00502585 |
| 18 | TGFBR1 | 1.97221693 |
| 19 | CSF1R | 1.74087860 |
| 20 | ZAK | 1.71172944 |
| 21 | OXSR1 | 1.63856908 |
| 22 | MAP4K2 | 1.63428559 |
| 23 | IRAK4 | 1.54861980 |
| 24 | FER | 1.54143679 |
| 25 | KDR | 1.52372139 |
| 26 | IKBKE | 1.51912347 |
| 27 | MAPKAPK3 | 1.50324463 |
| 28 | NUAK1 | 1.40698983 |
| 29 | VRK2 | 1.38512809 |
| 30 | ITK | 1.38378655 |
| 31 | RIPK4 | 1.33720556 |
| 32 | ADRBK2 | 1.32790592 |
| 33 | ACVR1B | 1.30740936 |
| 34 | LYN | 1.26748731 |
| 35 | JAK3 | 1.24857626 |
| 36 | MST4 | 1.23988251 |
| 37 | BCKDK | 1.23417395 |
| 38 | EIF2AK2 | 1.16186242 |
| 39 | PHKG2 | 1.13956290 |
| 40 | PHKG1 | 1.13956290 |
| 41 | MAP2K6 | 1.10757982 |
| 42 | TBK1 | 1.08013624 |
| 43 | FLT3 | 1.06538668 |
| 44 | BTK | 1.00141296 |
| 45 | SIK3 | 0.89741211 |
| 46 | GRK7 | 0.89242836 |
| 47 | PIK3CG | 0.87026411 |
| 48 | CDK9 | 0.84523537 |
| 49 | ADRBK1 | 0.83215367 |
| 50 | BLK | 0.78627511 |
| 51 | MAP2K1 | 0.73357046 |
| 52 | IKBKB | 0.72162104 |
| 53 | FGFR2 | 0.71750070 |
| 54 | MAP3K14 | 0.67811358 |
| 55 | LCK | 0.67682021 |
| 56 | INSRR | 0.66663757 |
| 57 | ERBB3 | 0.65310937 |
| 58 | ZAP70 | 0.64644056 |
| 59 | ABL1 | 0.59209001 |
| 60 | GRK5 | 0.59159114 |
| 61 | TXK | 0.58154562 |
| 62 | MATK | 0.57985428 |
| 63 | CHUK | 0.57227467 |
| 64 | CSNK1G3 | 0.56723725 |
| 65 | PRKCI | 0.55765965 |
| 66 | PLK2 | 0.53566380 |
| 67 | HCK | 0.53069154 |
| 68 | GRK6 | 0.52900801 |
| 69 | MAPKAPK5 | 0.51986286 |
| 70 | MAP2K3 | 0.50283737 |
| 71 | DAPK2 | 0.45972022 |
| 72 | ERN1 | 0.45676099 |
| 73 | STK39 | 0.45311612 |
| 74 | MAP2K2 | 0.45087889 |
| 75 | CAMKK1 | 0.41857699 |
| 76 | PRKCQ | 0.41614933 |
| 77 | TNK2 | 0.40075455 |
| 78 | VRK1 | 0.38401985 |
| 79 | CSK | 0.38085350 |
| 80 | PLK3 | 0.35441419 |
| 81 | PIK3CA | 0.35297097 |
| 82 | MAPK13 | 0.34818806 |
| 83 | PTK2B | 0.34782290 |
| 84 | PDK1 | 0.34279413 |
| 85 | IGF1R | 0.33880960 |
| 86 | RPS6KA5 | 0.32648249 |
| 87 | EGFR | 0.31427058 |
| 88 | WNK4 | 0.30178071 |
| 89 | TRIM28 | 0.28885094 |
| 90 | CSNK1G1 | 0.27746716 |
| 91 | TYK2 | 0.27026870 |
| 92 | CSNK1A1L | 0.26366726 |
| 93 | CSNK1G2 | 0.23535563 |
| 94 | PRKCA | 0.23279226 |
| 95 | MAP3K5 | 0.22959719 |
| 96 | TAF1 | 0.22950338 |
| 97 | PRKCD | 0.22924648 |
| 98 | CAMKK2 | 0.22579337 |
| 99 | MAPK3 | 0.22188914 |
| 100 | TRPM7 | 0.19843236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 6.47529838 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 5.41908688 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 5.15196770 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 5.12796887 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.04040517 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.40479871 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.46125173 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.20376174 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.94803717 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.89657403 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81858392 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.46475162 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.61491113 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60651678 |
| 15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.53626083 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.42598647 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38989021 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30355040 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16639005 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.15287934 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.05796481 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82173282 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77497955 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76264899 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72341891 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67815126 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64438362 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64403753 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 0.61769816 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 0.61237322 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55062035 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54794906 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51640689 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47230343 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47188723 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46039629 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45945446 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45935847 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43588160 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42875852 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.40531340 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38988653 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38343475 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35214647 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 0.33448228 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33447126 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.27140150 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.25565050 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23917711 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23839781 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23556299 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.23470184 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22875073 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22163081 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20658070 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20559779 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19899211 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.19821027 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.18719039 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17524646 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17191052 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16783951 |
| 63 | Homologous recombination_Homo sapiens_hsa03440 | 0.16621734 |
| 64 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14511992 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13659945 |
| 66 | Salivary secretion_Homo sapiens_hsa04970 | 0.13478431 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.13186744 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12116447 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.12100245 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.11899350 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.11380131 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.10132324 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.09316111 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.09299192 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.08481606 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.08309458 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.07013450 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06691211 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05481552 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.04490147 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.04300389 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.03888571 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03674237 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.03423342 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.03221787 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.02205178 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.01546644 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.00981157 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | -0.0440855 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0405153 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | -0.0362495 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | -0.0322516 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0313231 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | -0.0289165 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | -0.0236135 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | -0.0154781 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0071733 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | -0.0024532 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | -0.0012335 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0006484 |

